Search clinical trials for: Moderate facial rosacea

Total 8079 results

Padagis LLC

Completed

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Erythema | Rosacea

United States
Zydus Worldwide DMCC
Catawba Research, LLC

Completed

Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea

Facial Rosacea

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Rosacea

United States
Actavis Inc.
Watson Laboratories, Inc.

Completed

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

Rosacea

United States
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

Rosacea

United States
Burt's Bees Inc.
Dermatology Consulting Services, High Point NC

Completed

The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea

Rosacea

United States
Goldman, Butterwick, Fitzpatrick and Groff
RoC Opco LLC

Not yet recruiting

Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.

Redness
Proteocyte Diagnostics Inc.
The University of Texas Health Science Center, Houston; University of Alabama... and other collaborators

Recruiting

Evaluation of Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™

Mouth Diseases

United States
1st SurgiConcept
EVAMED

Recruiting

Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis. (ESTES)

Ptosis | Ptosis, Mild

France
Venus Concept

Recruiting

Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles

Wrinkle

United States
Ipsen

Recruiting

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines (LANTIC)

Moderate to Severe Upper Facial Lines

Germany, France
Insel Gruppe AG, University Hospital Bern

Active, not recruiting

Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea (KIR)

Rosacea

Switzerland
ZIIP Beauty
Dermatology Consulting Services, PLLC

Completed

Evaluation of the Safety and Efficacy of an Acne Treatment Device

Mild to Moderate Acne

United States
Merz North America, Inc.
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines (ULTRA I)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

United States
Alfasigma S.p.A.
bioRASI, LLC

Completed

Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

Papulopustular Rosacea

United States
Northwestern University

Completed

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Acne

United States
Allergan

Completed

A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence

Platysma Prominence

United States, Canada
Next Science TM
Jacksonville Center For Clinical Research; St. Johns Center for Clinical Research and other collaborators

Completed

A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne

Acne Vulgaris

United States
Galderma R&D

Completed

Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds

Skin Wrinkling

United States
Galderma R&D

Completed

Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds

Skin Wrinkling

United States
Ipsen

Terminated

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines. (LONG-SET)

Moderate Upper Facial Lines | Severe Upper Facial Lines

Germany
Galderma R&D

Completed

Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines (READY-4)

Lateral Canthal Lines | Glabellar Lines

United States, Puerto Rico
Galderma R&D

Completed

Treatment of Moderate to Severe Lateral Canthal Lines (READY-2)

Lateral Canthal Lines

United States, Canada
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Perioral Dermatitis

Germany
Dermatology Consulting Services, PLLC

Completed

Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea

Rosacea

United States
Cosmetique Active International

Completed

Efficacy of a Deep Cleansing Gel Containing 2% Salicylic Acid, 0.2% Zinc Gluconate and 0.05% Lipohydroxy Acid in the Management of Mild to Moderate Facial Acne

Acne Vulgaris on the Face

Brazil
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants

Dermatitis, Atopic | Rosacea | Acne Vulgaris | Sensitive Skin

United States
Unilever R&D
Shanghai Skin Disease and Venereal Disease Hospital

Completed

A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma

Melasma

China
AOBiome LLC
bioRASI, LLC

Completed

A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea

Rosacea

United States
Galderma R&D

Completed

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Rosacea

United States
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. (ULTRA II)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Germany
Laboratoires FILLMED

Completed

Evaluation of the Efficacy and Safety of Three Injectable Hyaluronic Acid-based Fillers: Art Filler® Fine Lines, Art Filler® Universal and Art Filler® Lips (AF4)

Loss of Face Volume

France
Vyne Therapeutics Inc.

Completed

A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Papulopustular Rosacea

United States
Galderma R&D

Completed

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Acne Vulgaris

United States
Northwestern University

Completed

Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness

Rosacea

United States
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea

Rosacea
Changi General Hospital

Completed

Efficacy of HFNC as an Alternative to CPAP Therapy in Surgical Patients With Suspected Moderate to Severe OSA

OSA

Singapore
Galderma R&D

Completed

Patient-Reported Outcome Of Facial Erythema (PROOF) (PROOF)

Erythema | Rosacea

United Kingdom, Germany, Sweden
Galderma R&D

Completed

Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States, Canada
Galderma R&D

Completed

MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. (MOSAIC)

Rosacea

United States, Canada
Galderma R&D

Completed

Treatment of Patients With Blepharitis and Facial Rosacea

Dry Eye | Blepharitis | Meibomianitis

United States
Galderma R&D

Completed

Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%

Erythematous Rosacea

United States
Galderma R&D

Completed

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States, Canada
Galderma R&D

Completed

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
Janssen Research & Development, LLC

Completed

Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Vyne Therapeutics Inc.
Premier Research Group plc

Completed

A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea

Facial Papulopustular Rosacea

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States

3

Subscribe